CD8A and COVID-19: After grading disease severity in the participants resulting infected during that period, we retrospectively examined how CD4+ and CD8+ T cells and monocyte subpopulations responded in vitro to anti-CD3, anti-CD28, poly I:C, spike protein, and lipopolysaccharide (LPS) in seeking a basal immune pattern that could associate with the development of mild or severe COVID-19.